SAN FRANCISCO--(BUSINESS WIRE)--Feb. 22, 2005--Dynarand, a leader in interactive voice response (IVR) and Web systems for clinical trials, is featured in today's edition of The New York Times highlighting the company's inception and growth over the past few years. The article focuses on the entrepreneurial ventures of the founders and how this start-up came to fruition.
The company began as an idea Scott Hamilton had in 1998. Hamilton was a biostatistician working at Genentech, who identified the need for a quality IVR vendor for pharmaceutical and biotechnology companies to conduct clinical trials. Hamilton showed the business plan to his brother in-law, Jonathan Dole, and they started to set groundwork for their company. Dole had experience in telecommunications, information technology and computer science. His experience, coupled with Hamilton's background, was the perfect combination for this business venture.
They envisioned a company encompassing patient randomization, drug inventory management and electronic patient diaries, all via the use of the telephone. The two worked on preliminary systems based out of Hamilton's garage for the first year and in 1998, they formed Dynarand, short for dynamic randomization.
Since its inception, Dynarand has grown exponentially and provides services to companies worldwide. To date, the company has provided systems for over 150 trials involving over 50,000 patients, including domestic and international sites. In addition, Dynarand has the capability of providing systems in any language.
Dynarand is currently in its 7th year of business and now has approximately 40 employees. The company takes full advantage of its location in San Francisco and proximity to the Silicon Valley by hiring highly talented software developers and engineers. Dynarand prides itself on a high level of customer service, which is attributed to the involvement and attentiveness of the company's Client Services department. Recently, the company is focusing on business development and expansion in the European market.
Over the years, Dynarand has paid special attention to client needs and developing IVR-based systems and web-based systems, too. The web-based systems allow for clients to utilize computers as the user-interface for randomization, inventory management, data collection and reporting. Dynarand has developed a solid reputation and continues to improve clinical trial management by providing some of the most efficient and reliable IVR/Web systems in the industry.
MULTIMEDIA AVAILABLE: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=4827954